Items 101 to 110 of 126 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
POV-PC | 121324-31-0 | sc-205441 sc-205441A | 1 mg 10 mg | $108.00 $1163.00 | ||
POV-PC is a specialized acid halide that engages in selective acylation reactions, influencing lipid metabolism and cellular signaling pathways. Its unique reactivity with nucleophiles enables the formation of stable intermediates, which can modulate enzyme activity in cardiomyocytes. The compound's ability to form strong hydrogen bonds enhances its interaction with biomolecules, potentially altering membrane fluidity and ion channel dynamics, thereby affecting cardiac function at a molecular level. | ||||||
15-epi Prostaglandin A1 | 20897-92-1 | sc-205020 sc-205020A | 1 mg 5 mg | $49.00 $222.00 | ||
15-epi Prostaglandin A1 is a bioactive compound that plays a pivotal role in modulating vascular tone and platelet aggregation. Its unique structure allows for specific interactions with G-protein coupled receptors, triggering intracellular signaling cascades that influence smooth muscle contraction and relaxation. The compound's affinity for lipid bilayers enhances its bioavailability, facilitating rapid diffusion across membranes and impacting cellular responses in cardiac tissues. | ||||||
β-Methyl Digoxin | 30685-43-9 | sc-219473 | 2.5 mg | $320.00 | ||
β-Methyl Digoxin is a cardiac glycoside characterized by its ability to selectively inhibit Na+/K+ ATPase, leading to increased intracellular sodium levels. This alteration enhances calcium influx via the sodium-calcium exchanger, promoting stronger myocardial contractions. Its unique stereochemistry contributes to its binding affinity, influencing the kinetics of cardiac muscle contraction and relaxation. Additionally, β-Methyl Digoxin exhibits distinct solubility properties, affecting its distribution in biological systems. | ||||||
Mevinolinic acid, monoammonium salt | 77550-67-5 | sc-221939 | 100 mg | $1980.00 | ||
Mevinolinic acid, monoammonium salt, is a potent inhibitor of HMG-CoA reductase, a key enzyme in the cholesterol biosynthesis pathway. Its unique structure allows for specific interactions with the enzyme's active site, effectively altering the reaction kinetics and reducing the production of mevalonate. This modulation of lipid metabolism can influence cellular signaling pathways, impacting vascular health. The compound's solubility characteristics also facilitate its interaction with lipid membranes, enhancing its bioavailability in various biological environments. | ||||||
4-[4-(1-Pyrrolidinyl)phenyl]-1,3-thiazol-2-ylamine | 784136-89-6 | sc-315457 sc-315457A | 1 mg 5 mg | $69.00 $78.00 | ||
4-[4-(1-Pyrrolidinyl)phenyl]-1,3-thiazol-2-ylamine exhibits intriguing properties in cardiology through its ability to modulate ion channel activity and influence cardiac myocyte function. Its thiazole ring enhances binding affinity to specific receptors, potentially altering intracellular calcium dynamics. The compound's unique molecular interactions may affect signal transduction pathways, contributing to the regulation of cardiac contractility and rhythm. Additionally, its lipophilic nature allows for effective membrane penetration, impacting cellular responses in cardiac tissues. | ||||||
(±)13-HODE cholesteryl ester | 167354-91-8 | sc-204992 sc-204992A | 25 µg 50 µg | $88.00 $166.00 | ||
(±)13-HODE cholesteryl ester plays a significant role in cardiology by influencing lipid metabolism and cellular signaling pathways. Its unique structure facilitates interactions with membrane receptors, potentially modulating inflammatory responses and oxidative stress in cardiac tissues. The esterification of 13-HODE enhances its hydrophobicity, promoting incorporation into lipid rafts, which may affect protein localization and signaling cascades critical for maintaining cardiovascular health. | ||||||
(E)-Fluvoxamine-d3 Maleate | 1185245-56-0 | sc-218288 | 1 mg | $450.00 | ||
(E)-Fluvoxamine-d3 Maleate exhibits intriguing properties in cardiology through its ability to modulate neurotransmitter systems that influence cardiovascular function. Its unique stereochemistry allows for selective binding to serotonin receptors, potentially impacting vascular tone and heart rate regulation. Additionally, its interactions with ion channels may alter cardiac excitability, while its solubility characteristics facilitate distribution within lipid membranes, influencing cellular signaling dynamics. | ||||||
Na+/H+ Exchanger Isoform-1 Inhibitor | 861218-38-4 | sc-222035 sc-222035A sc-222035B | 10 mg 50 mg 100 mg | $2440.00 $1240.00 $2000.00 | ||
Na+/H+ Exchanger Isoform-1 Inhibitor plays a pivotal role in cardiology by selectively disrupting ion transport mechanisms that regulate intracellular pH and sodium levels. Its unique binding affinity to the exchanger alters cellular homeostasis, influencing cardiac myocyte function and contractility. By modulating specific signaling pathways, it can affect hypertrophic responses and cellular stress, ultimately impacting cardiac remodeling and function. | ||||||
EHNA hydrochloride | 51350-19-7 | sc-201184 sc-201184A | 10 mg 50 mg | $104.00 $379.00 | 6 | |
EHNA hydrochloride is a potent inhibitor of adenosine deaminase, influencing purine metabolism and nucleotide signaling in cardiac tissues. Its unique interaction with the enzyme alters the balance of adenosine and its metabolites, which can modulate vascular tone and myocardial oxygen demand. By affecting the kinetics of adenosine accumulation, EHNA hydrochloride can influence cardiomyocyte energy metabolism and contribute to the regulation of cardiac rhythm and function. | ||||||
15(S)-15-methyl Prostaglandin D2 | 85280-90-6 | sc-205569 sc-205569A | 1 mg 5 mg | $118.00 $578.00 | ||
15(S)-15-methyl Prostaglandin D2 is a bioactive lipid that plays a crucial role in cardiovascular physiology. It selectively binds to specific receptors, triggering pathways that modulate vascular smooth muscle contraction and endothelial function. This compound influences the release of nitric oxide, enhancing vasodilation and blood flow. Its unique structural features allow for distinct interactions with G-protein coupled receptors, impacting inflammatory responses and platelet aggregation in the cardiovascular system. | ||||||